The Edible Plant Crithmum maritimum Shows Nutraceutical Properties by Targeting Energy Metabolism in Hepatic Cancer

Plant Foods Hum Nutr. 2022 Sep;77(3):481-483. doi: 10.1007/s11130-022-00986-z. Epub 2022 Jul 14.

Abstract

In the past few years, evidence has supported the role of plants as a valuable tool for the development of promising therapeutic support options for many diseases, including cancer. We recently discovered that the edible wild plant Crithmum maritimum L. effectively inhibits the growth of hepatocellular carcinoma (HCC) cells and we provide insights into the biological mechanisms involved. Here, we aimed to characterize the effect of ethyl acetate extract of Crithmum maritimum on the bioenergetic phenotype of HCC cells and if this is associated with the anti-tumour effect we previously described. Results show that Crithmum maritimum significantly increases cellular respiration and reduces lactic fermentation in HCC cells, and that this reduction of the fermentative glycolytic phenotype is linked to inhibition of HCC growth. These data provide new preclinical evidence supporting the role of Crithmum maritimum L. as a nutraceutical option to expand the therapeutic opportunities in the management of HCC.

Keywords: Anticancer activity; Bioenergetic phenotype; Crithmum maritimum L.; Edible wild plants; Hepatocellular carcinoma; Plant extracts.

Publication types

  • Review

MeSH terms

  • Apiaceae*
  • Carcinoma, Hepatocellular* / drug therapy
  • Dietary Supplements
  • Energy Metabolism
  • Liver Neoplasms* / drug therapy
  • Plant Extracts / pharmacology
  • Plants, Edible

Substances

  • Plant Extracts